UNEEG Medical

Focus: UNEEG Medical is a Danish biotech specialist in ultra long-term, subcutaneous EEG monitoring systems for neurology and metabolic disease applications. The company operates at pre-revenue scale with a lean team of 1–50 employees focused on device-based innovation.

Neurology Metabolic Diseases

Profile data last refreshed 13h ago · AI intelligence enriched 3w ago

Employees

1-50

Open Jobs

About UNEEG Medical

AI assessmentNot Hiring

No open roles listed right now. Follow UNEEG Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

19 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes

Hypoglycemia

N/A

Clinical Trials (1)

NCT00810420EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes

N/A

Help build intelligence for UNEEG Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep technical specialization in a novel, uncontested niche (subcutaneous long-term EEG) with 18 active clinical trials demonstrating sustained R&D momentum.
Early-stage opportunity to shape product-market fit and regulatory strategy in epilepsy and diabetes monitoring before scale-up hiring.
Founded 2005 signals survival through multiple cycles; 5 publications show active scientific credibility and potential for high-impact clinical partnerships.

Watch Out For

Pre-revenue status with no public funding data means zero job security and material burn-rate risk; equity upside is speculative without exit signal.
Zero active job postings and 1–50 headcount indicate severely limited hiring; entry depends on founder network or serendipitous opening.
Early-stage device regulation (no Phase 1–3 designations visible) carries extended timelines to revenue; clinical validation still uncertain across 18 trial programs.

Generated by Claude from UNEEG Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Short-term Baseplates first then long-term Baseplates

Healthy Subjects

N/A

Clinical Trials (1)

NCT05111847Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part I

N/A

24/7 EEG™ SubQ

Sleep

N/A

Insulin clamp

Hypoglycaemia

N/A